SmPC - Zercepac 150 mg powder for concentrate for solution for infusion: Change history
View Summary of Product Characteristics (SmPC - Zercepac 150 mg powder for concentrate for solution for infusion)
Last updated on this site: 21 Apr 2026
Description of update: To update Sections 2, 4.4, and 6.1 of the SmPC in line and align with the reference product information Herceptin. Consequently, the PIL has been updated.
Date of approval: 07/04/2026
SmPC sections updated: 2, 4.4, 6.1 and 10
View Summary of Product Characteristics (SmPC - Zercepac 150 mg powder for concentrate for solution for infusion)
Last updated on this site: 21 Apr 2026
Description of update: To update Sections 2, 4.4, and 6.1 of the SmPC in line and align with the reference product information Herceptin. Consequently, the PIL has been updated.
Date of approval: 07/04/2026
SmPC sections updated: 2, 4.4, 6.1 and 10
-
Changes: (Updated: 21 Apr 2026)
Description of update: To update Sections 2, 4.4, and 6.1 of the SmPC in line and align with the reference product information Herceptin. Consequently, the PIL has been updated.
Date of approval: 07/04/2026
SmPC sections updated: 2, 4.4, 6.1 and 10
-
Changes: (Updated: 25 Feb 2025)
Renewal Approval
-
Changes: (Updated: 04 Sep 2023)
To register a change in the ATC code following a WHO Recommendation from "L01XC03" to "L01FD01." Consequentially, section 5.1 of the SmPC has been updated.
-
Changes: (Updated: 03 Nov 2022)
Initial upload